HONOLULU – The Hawai‘i Department of Health (DOH) is adopting the most recent COVID-19 booster shot recommendations issued by the Centers for Disease Control and Prevention (CDC).

Effective immediately:

  • DOH recommends a single Pfizer-BioNTech (Pfizer) vaccine booster shot for everyone ages 12 – 17 who completed their primary vaccine series at least five months ago.
  • People 18 and older who completed their primary series of Pfizer vaccine at least five months ago should get an mRNA (Pfizer or Moderna) booster.
  • Moderately to severely immunocompromised children ages 5-11 should get an additional dose of the Pfizer vaccine 28 days after their second shot.

“It is important all people covered by these new recommendations take advantage of the extra layer of protection that booster shots provide. They ramp up the level of your neutralizing antibodies tremendously,” said State Health Director Dr. Elizabeth Char, FACEP.

The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed.

Only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children aged 5-11.

Vaccination and testing options are available at hawaiicovid19.com

# # #

PDF: Booster shot eligibility expands

Categories: News Releases, Vaccine
Recent Posts

Hawai‘i COVID-19 hospitalizations on the rise

HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]

Wastewater Samples Show Higher COVID Concentrations & New Subvariant

The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]

Bivalent boosters for keiki as young as 6 months

Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]

Select Archive Month